253 related articles for article (PubMed ID: 32998392)
1. Early Stimulation of TREK Channel Transcription and Activity Induced by Oxaliplatin-Dependent Cytosolic Acidification.
Dionisi M; Ruffinatti FA; Riva B; Lim D; Canta A; Meregalli C; Fumagalli G; Monza L; Ferrer-Montiel A; Fernandez-Carvajal A; Cavaletti G; Genazzani AA; Distasi C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998392
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors.
Potenzieri A; Riva B; Rigolio R; Chiorazzi A; Pozzi E; Ballarini E; Cavaletti G; Genazzani AA
Pain; 2020 Feb; 161(2):405-415. PubMed ID: 31634341
[TBL] [Abstract][Full Text] [Related]
3. Characterization of temperature-sensitive leak K
Viatchenko-Karpinski V; Ling J; Gu JG
Mol Brain; 2018 Jul; 11(1):40. PubMed ID: 29980241
[TBL] [Abstract][Full Text] [Related]
4. Selective Small Molecule Activators of TREK-2 Channels Stimulate Dorsal Root Ganglion c-Fiber Nociceptor Two-Pore-Domain Potassium Channel Currents and Limit Calcium Influx.
Dadi PK; Vierra NC; Days E; Dickerson MT; Vinson PN; Weaver CD; Jacobson DA
ACS Chem Neurosci; 2017 Mar; 8(3):558-568. PubMed ID: 27805811
[TBL] [Abstract][Full Text] [Related]
5. GI-530159, a novel, selective, mechanosensitive two-pore-domain potassium (K
Loucif AJC; Saintot PP; Liu J; Antonio BM; Zellmer SG; Yoger K; Veale EL; Wilbrey A; Omoto K; Cao L; Gutteridge A; Castle NA; Stevens EB; Mathie A
Br J Pharmacol; 2018 Jun; 175(12):2272-2283. PubMed ID: 29150838
[TBL] [Abstract][Full Text] [Related]
6. PIP
Rivas-Ramírez P; Reboreda A; Rueda-Ruzafa L; Herrera-Pérez S; Lamas JA
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936257
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity.
Pereira V; Lamoine S; Cuménal M; Lolignier S; Aissouni Y; Pizzoccaro A; Prival L; Balayssac D; Eschalier A; Bourinet E; Busserolles J
Mol Neurobiol; 2021 Jul; 58(7):3575-3587. PubMed ID: 33772465
[TBL] [Abstract][Full Text] [Related]
8. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].
Taguchi K
Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807
[TBL] [Abstract][Full Text] [Related]
9. Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin.
Poupon L; Lamoine S; Pereira V; Barriere DA; Lolignier S; Giraudet F; Aissouni Y; Meleine M; Prival L; Richard D; Kerckhove N; Authier N; Balayssac D; Eschalier A; Lazdunski M; Busserolles J
Neuropharmacology; 2018 Sep; 140():43-61. PubMed ID: 30056126
[TBL] [Abstract][Full Text] [Related]
10. Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current.
Sittl R; Lampert A; Huth T; Schuy ET; Link AS; Fleckenstein J; Alzheimer C; Grafe P; Carr RW
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6704-9. PubMed ID: 22493249
[TBL] [Abstract][Full Text] [Related]
11. Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons.
Leo M; Schmitt LI; Küsterarent P; Kutritz A; Rassaf T; Kleinschnitz C; Hendgen-Cotta UB; Hagenacker T
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207782
[TBL] [Abstract][Full Text] [Related]
12. Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception.
Pereira V; Busserolles J; Christin M; Devilliers M; Poupon L; Legha W; Alloui A; Aissouni Y; Bourinet E; Lesage F; Eschalier A; Lazdunski M; Noël J
Pain; 2014 Dec; 155(12):2534-2544. PubMed ID: 25239074
[TBL] [Abstract][Full Text] [Related]
13. Formation of Functional Heterodimers by TREK-1 and TREK-2 Two-pore Domain Potassium Channel Subunits.
Lengyel M; Czirják G; Enyedi P
J Biol Chem; 2016 Jun; 291(26):13649-61. PubMed ID: 27129242
[TBL] [Abstract][Full Text] [Related]
14. Colitis decreases mechanosensitive K2P channel expression and function in mouse colon sensory neurons.
La JH; Gebhart GF
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G165-74. PubMed ID: 21512155
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity.
Chukyo A; Chiba T; Kambe T; Yamamoto K; Kawakami K; Taguchi K; Abe K
Neuropeptides; 2018 Feb; 67():95-101. PubMed ID: 29274843
[TBL] [Abstract][Full Text] [Related]
16. Activation of TREK currents by the neuroprotective agent riluzole in mouse sympathetic neurons.
Cadaveira-Mosquera A; Ribeiro SJ; Reboreda A; Pérez M; Lamas JA
J Neurosci; 2011 Jan; 31(4):1375-85. PubMed ID: 21273422
[TBL] [Abstract][Full Text] [Related]
17. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy.
Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A
Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292
[TBL] [Abstract][Full Text] [Related]
18. TRESK and TREK-2 two-pore-domain potassium channel subunits form functional heterodimers in primary somatosensory neurons.
Lengyel M; Czirják G; Jacobson DA; Enyedi P
J Biol Chem; 2020 Aug; 295(35):12408-12425. PubMed ID: 32641496
[TBL] [Abstract][Full Text] [Related]
19. Intracellular acidification is associated with changes in free cytosolic calcium and inhibition of action potentials in rat trigeminal ganglion.
Hwang SM; Koo NY; Jin M; Davies AJ; Chun GS; Choi SY; Kim JS; Park K
J Biol Chem; 2011 Jan; 286(3):1719-29. PubMed ID: 21068392
[TBL] [Abstract][Full Text] [Related]
20. Neuronal microRNAs modulate TREK two-pore domain K
Paschou M; Maier L; Papazafiri P; Selescu T; Dedos SG; Babes A; Doxakis E
RNA Biol; 2020 May; 17(5):651-662. PubMed ID: 31994436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
